×
Outcomes of Relapsed/Refractory Patients with IDH1/2 Mutated AML Treated with Non-Targeted Therapy: Results from the NCRI AML Trials
Hills RK., Gale R., Linch DC., Huntly BJP., Papaemmanuil E., Vyas P., Burnett AK., Russell NH.
DOI
10.1182/blood-2018-99-116482
Type
Conference paper
Publication Date
2018-01-01T00:00:00+00:00
Volume
132